Antitrust Antitrust

South Korea's Daewoong Pharmaceutical sanctioned for filing fake patent infringement litigation

By Jenny Lee
  • 03 Mar 2021 01:16
  • 03 Mar 2021 01:16
Daewoong Pharmaceutical was slapped with sanctions today by the South Korean antitrust regulator for abusing the country's patent infringement litigation system.

In a statement released today, the Korea Fair Trade Commission, or KFTC, imposed a corrective order and a fine of 2.27 billion won ($2 million) on Daewoong for unreasonably filing patent

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News